4 Results for "

PROTAC AURKA degrader1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PROTAC AURKA degrader1" in MCE Product Catalog:

Cat. No.: HY-175830
Target:  

PROTACs Aurora Kinase

Research Areas:  

Cancer

PROTAC AURKA degrader 1 is a AURKA PROTAC degrader . PROTAC AURKA degrader 1 forms a ternary complex with AURKA and CRBN E3 ligase, labels AURKA to induce its ubiquitination, and promotes its degradation via the ubiquitin-proteasome system. PROTAC AURKA degrader 1 is applicable to leukemia-related research .
loading...
    loading...
Cat. No.: HY-168540
Research Areas:  

Cancer

PROTAC MPS1 degrader 1 is a selective monopolar spindle 1 (Mps1/TTK) PROTAC degrader, with DC50 values of 17.7, 108.67 and 570.25 nM against TTK, AURKA and AURKB, respectively. PROTAC MPS1 degrader 1 exhibits cytotoxicity against acute myeloid leukemia cells. PROTAC MPS1 degrader 1 can be used in research related to acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-175827
MK-5108-NH-PEG2-alkyne is a Aurora kinase A (AURKA) inhibitor. MK-5108-NH-PEG2-alkyne can be used for synthesis of PROTAC AURKA degrader 1 (HY-175830) .
loading...
    loading...
Cat. No.: HY-181568
CAS No.: 3115344-59-4
PROTAC Aurora A Degrader-1 is an orally active and blood-brain barrier-permeable selective Aurora A PROTAC degrader. PROTAC Aurora A Degrader-1 induces AURKA degradation with a DC50 of 6 nM in IMR32 cells (Dmax = 95%), eliminates both the kinase catalytic activity and N-Myc stabilizing scaffolding function of Aurora A, induces DNA damage, G2/M arrest and apoptosis, and shows antiproliferative activity. PROTAC Aurora A Degrader-1 is applicable to the research of neuroblastoma and small cell lung cancer .
loading...
    loading...